chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Normal fatigue, slight fever and chills within the first 24 hours which dissipated over time.  48 hours after vaccination, woke up covered in measle type hives located all over body.  Was seen at urgent care and prescribed predisone to take on Tuesday (5 days after shot) if symptoms worsened or persisted.  Fever rose to 102, and hives became worse.  Swollen lips, face, with flattened welts covering entire body.   Welts were itchy, and uncomfortable and showed no signs of recovery until predisone was taken.  Fever persisted for 5 days with continual outbreaks.
Terrible headache; Vomiting; Diarrhea; Muscle aches; Weakness; Queasy stomach; Loss of appetite; This is a spontaneous report from a contactable consumer or other non-HCP (patient herself). A 68-year-old female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number-UNKNOWN) via unspecified route of administration in arm (reported as shoulder) on 11Mar2021 (at the age of 68-years-old) as dose 2, single for COVID-19 immunization. Patient was not pregnant at the time of vaccination. Vaccination facility type was reported as Pharmacy or Drug Store. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient not diagnosed with COVID-19. Since the vaccination, has the patient not been tested for COVID-19. Patient did not have COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. Patient medical history included Hypothyroidism due to total thyroidectomy. Historical vaccine included BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration on 25Feb2021 15:45 as dose 1, single for COVID-19 immunization and experienced constant runny nose similar to a bad head cold for two days. The concomitant medications include thyroid (ARMOUR THYROID). The patient experienced terrible headache, vomiting, diarrhea, muscle aches, weakness for 48 hours and queasy stomach, loss of appetite for 3+ days later on an unspecified date in Mar2021. The outcome of events was resolved on an unspecified date in Mar2021.
chills and low grade fever, body and head aches, sensitivity at injection site, nausea, fatigue
Woke up the next morning after his shots were given with hives all over both legs and both arms.  Per Dr's office, give Benedryl.  In the evening of 3/23/06, hives more severe and all over his body and face.  Went to ER per Dr's instructions after oral Predisone did not relieve hives.
The patient has a 2 1/2 inch area of induration, swelling and erythema which developed around the injection site 24 hours after the vaccination.
Patient was getting 1st booster vaccine (pfizer). After vaccine was given, the administrator noticed patient already got 1st booster and the shot she got today should be second booster. But second booster is not approved for non-immunocompromised patients.  Informed mother of the mistake and she said it was okay. She said she can't remember that her daughter got the first booster and believes her daughter did not get the first booster shot even though it is on her vaccine card.
Pt. c/o leg pain/numbness/headaches. As PE WNL except tenderness on calf. Neuro intact. Care discussed with parent by MD 6/7/1011.
COVID infection test resulted 8/3/21.  symptoms started 7/31/21: subjective fever, loss of taste/smell, fatigue, headache.  Currently remains symptomatic.
Pt reported rash with hives around her neck...small rash at site of injection also. She is not having breathing problems but was concerned about hives. She did not want to contact her doctor at this time.
Patient had 2nd vaccine on 2/24/21.  Patient had COVID test on 4/1/21 prior to outpatient surgery.  COVID test came back positive. Patient is asymptomatic and has not had a previous COVID test. Pt did not have other adverse reaction to vaccine other than positive test >14 days after 2nd vaccine shot
Tinnitus, doctor referred me to ear, nose, and throat physician. Hearing test completed. Diagnosis was loss of hearing. Loss of hair in cholera.
CDC reports: 1 yo child developed fever to 106 & convuls (2) following immun. Lumbar puncture normal. Duration of illness 4 days. 13FEB90 dx "early otitis media".
Seen 9/19/07 for 8 year old WCV received flu vaccine woke up 9/20/07 with red, swollen, hot arm at injection site. Diagnosed with Cellulitis treated with Keflex.
"Covid  arm"  Reddened area approx  2 inches in diameter with induration and moderate itching
Hep B was supposed to be given. Hep was given instead. Patient reported no symptoms of illness.
PATIENT REPORTS PAIN IN HER RIGHT ARM FROM VACCINATION THAT HAS NOT RESOLVED. SHE HAS NOT SOUGHT MEDICAL TREATMENT AT THIS TIME AND REFUSED THE PHARMACY TO CALL HER PHYSICIAN.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 25-APR-2018, the patient was vaccinated with an improperly stored dose of PEDVAXHIB, lot # N022167, expiration date: 08-FEB-2020 (dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 47 to 77 degrees Fahrenheit for 5 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1806USA001505: US-009507513-1806USA009027: US-009507513-1806USA009028: US-009507513-1806USA009029: US-009507513-1806USA009030: US-009507513-1806USA009031: US-009507513-1806USA009032: US-009507513-1806USA009033: US-009507513-1806USA009034: US-009507513-1806USA009035: US-009507513-1806USA009036: US-009507513-1806USA009037: US-009507513-1806USA009038: US-009507513-1806USA009039: US-009507513-1806USA009040: US-009507513-1806USA009041: US-009507513-1806USA009042: US-009507513-1806USA009043: US-009507513-1806USA009044: US-009507513-1806USA009045: US-009507513-1806USA009046: US-009507513-1806USA009047: US-009507513-1806USA009048: US-009507513-1806USA009049: US-009507513-1806USA009050: US-009507513-1806USA009051: US-009507513-1806USA009052: US-009507513-1806USA009053: US-009507513-1806USA009054: US-009507513-1806USA009055: US-009507513-1806USA009056.
NO ADVERSE REACTIONS AT TIME OF VACCINATION. CHILD WAS EXAMINED BY PHYSICIAN AND DEEMED HEALTHY. CHILD WENT HOME ALERT AND SHOWING NO NEGATIVE SYMPTOMS BUT WE WERE ADVISED BY CORONER'S OFFICE ON FEBRUARY 14, 2008 THAT BABY DIED. CORONER'S OFFICE DOES NOT KNOW CAUSE OF DEATH -- POSSIBLE SIDS.    2/19/08 Reviewed provisional autopsy which states COD as SIDS.  Patient co-sleeping w/parents & unresponsive when parent awoke.  Both parents smoke in home.  Mother w/gestational diabetes.  Home unkept & narcotics found in home.  3/13/08 Reviewed autopsy report which is unchanged from prelim autopsy.
Received booster vaccination on Thursday (10/28).  Friday I felt achy but nothing that kept me down.  On Sat. 10/30 I had at least a 4.5 x 3 inch lymphadenopathy under my left axilla.  It was very prominent.  I had no reaction with my first J&J shot.  Today yet I still have soreness in my left arm.  Nothing painful but I did not have that with my first shot.  Today the lymphadenopathy is not as bad but still persists.  The lymph node(s) are sore not painful.  Yesterday I had some numbness in my distal hand but that seems to have resolved.     I have never had any reactions to any type of vaccinations like this.  Truly this type of reaction concerns me and makes me hesitant to ever get additional Covid vaccinations.
Chills, back ache, elevated pulse(115) started about 12 hours after vaccination. Lasted about 8 hours.  Called cardiologist and he said it was probably a reaction to the vaccine.  Took some ibuprofen.  Did not do anything else.  Felt better the next morning and pulse was fluctuating between 80 and 90.
Pt received 0.3ml of undiluted Pfizer vaccine.  Error was not discovered until after the dose had been administered. Patient contacted regarding dosing error and was made aware of possible symptoms to monitor for.  Patient complained of arm soreness at the injection site.
severe bloating; severe diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) in the left arm on an unknown date in Mar2021 at 10:00 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included chronic dermatology issues. Concomitant medications included bupropion (MANUFACTURER UNKNOWN), cetirizine (MANUFACTURER UNKNOWN), tamsulosin (MANUFACTURER UNKNOWN), clobetasol (MANUFACTURER UNKNOWN) and cetrimide; lidocaine hydrochloride; triamcinolone acetonide (TRI), all from an unknown date for unspecified indication. The patient previously took Bacitracin and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2021 at 16:00 (after two weeks of vaccination), the patient experienced severe bloating and severe diarrhea. No therapeutic measures were taken as a result of reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events severe bloating and diarrhea was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Patient developed right eye redness and swelling a day after receiving the second dose of the Coronavirus vaccine.
Talked with patient on 1/22/07. Patient said her arm was sore after taking the Flu shot, but soreness had gone away until she started working out. She said she had problem,s lifting her dumbbells. She also said she had problem putting her coat on. She says it doesn't bother her unless she lifts weights. Shot was given on 11/2/06 by a Nursing Student from Nursing School. She is just reporting this to the health department. Patient has not been to see MD for this problem. I instructed patient to see MD asap for evaluation. When I asked patient why she waited this long she said her husband kept telling her that it's ok and it will get better. I instructed her to see MD asap and not to wait any longer. When I asked patient if there was any redness, swelling or heat coming from her arm she said No.
redness, swelling, and warmth to right arm a few inches below where shot was given. Injection site however shows no redness, swelling or warmth.
At first just had small red itchy bumps on arms  that would come and go but over the next few weeks the bumps got bigger and would spread throughout her body. Doctor said they were hives and advised us to use Zyrtec and get blood work to see if it was an allergy. Blood work said she was having an autoimmune response to something she had the first GARDASIL 9 shot on 07/13/2016 and the second shot on 09/15/2016  she noticed the hives on 10/10/16 while she was in class and her arms were itching bad. We treated it with Benadryl but Over the next few weeks it got worse and worse and was covering her whole body and the Benadryl wasn't enough. We went to her primary doctor who send us to an allergist who ordered blood work and found out it wasn't an allergic reaction it was an autoimmune response. She has been healthy besides the hives so we can't figure out what triggered her immune system except for one of these immunization shots.  Now she has to take an antihistamine two times a day and is always worried she will have a breakout.
This spontaneous report was received from a Pharmacist, referring to unspecified number of patients of unknown age and gender. No pertinent medical history, drug reactions/allergies or concurrent conditions were reported. On an unknown date, the patients were vaccinated with 9 dose of improperly stored PROQUAD (which had a lot # of L016393 and an expiration date of 08-NOV-2017; however, dosage number and route of administration were not reported. Nonetheless, no adverse effects were reported. Another batch of VARIVAX (which had a lot # of L045678 and an expiration date of 09-MAY-2017; and a report lot # as M002056 with expiration date on 11-JUL-2017) had also been improperly stored and had been administered. The vaccines experienced the following temperature excursions on the following dates: 21 F for 5 hours. Reportedly, there had been no previous temperature excursions and the aforementioned ones were identified due to a data logger. Furthermore, no product quality complaint was involved. This is one of the several reports received from the same reporter. Additional information has been requested.
When RN was initially doing the injection, the safety mechanism on the needle was partially raised which prevented the needle from fully going into the arm and "much of the vaccine" leaked out of arm. Pt received unknown amount of vaccine. Per CDC guidance, if unknown amount of vaccine administered then repeat full dose in opposite arm, which was done.
-Acute psychosis resulting in severe anxiety and intrusive thoughts -Chest pain, shortness of breath, diarrhea, loss of appetite, fatigue
Sore arm began on the date of vaccine administration, worsened throughout the evening, was slightly less the following day, and completely gone the day after.  Swollen and sore lymph nodes in left armpit began the Tuesday following administration (on 4/27/2021) and continued through May 1st.
Erythema of both thighs 2 days after vaccines. Largest ones of erythema L thigh 2 " by 1.5 ".  Non tender - local reaction.
Child received #2 Hepatitis A vaccination in the right thigh approximately one year ago at the age of approximately 18 months.  There was some localized swelling.  In the past year the leg has strophied and child is limping.  He has been seen by pediatrcians and been referred to an orthopedist.  It was suggested that perahps it was the vaccine.
Dose of the Moderna Covid vaccine is given after the expiration; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose of the Moderna Covid vaccine is given after the expiration) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose of the Moderna Covid vaccine is given after the expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose of the Moderna Covid vaccine is given after the expiration) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were provided by the reporter  No treatment medication were provided by the reporter
Became pale, limp, & lifeless, 2hrs post vax; Unreponsive to stimulation;
patient was administered (5-July-2023 priorix after a below temperature excursion inadvertently; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a 43-year-old female patient who received MMR (Priorix) (batch number AA25SS, expiry date 01-NOV-2024) for prophylaxis.   On 05-JUL-2023, the patient received the 2nd dose of Priorix. On an unknown date, an unknown time after receiving Priorix, the patient experienced incorrect storage of drug (Verbatim: patient was administered (5-July-2023 priorix after a below temperature excursion inadvertently). The outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date 5 Jul 2023 Nurse reported that the patient was administered priorix after a below temperature excursion inadvertently. The reporter consented to follow up.  The Vaccine Administration Facility was the same as Primary Reporter. The patient was administered priorix after a below temperature excursion inadvertently which led to incorrect storage of drug.
Initial information received on 26-Feb-2019 regarding an unsolicited valid non-serious case received from a physician by phone. This case involves adult patient of an unknown demographics who experienced arm pain, while received vaccine FLUZONE HIGH DOSE. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications were not reported. On an unknown date in November, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (lot number, expiry date, dose, dose in series, route and site of administration were not reported). On an unknown date, the patient developed a non-serious arm pain (pain in extremity) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE. No lab data was reported. Final diagnosis was arm pain. It was not reported if the patient received a corrective treatment.The patient outcome is not reported for arm pain. Documents held by the sender: none.
Runny nose and scratchy throat on July 11, 2022.  Positive home antigen test on July 11, 2022.  Nausea with vomiting and cough on July 12, 2022.  Started 5 day course of Paxlovid on July 12, 2022.  Symptoms improved but then worsened again on July 21, 2022.  Home antigen test was positive on July 21, 2022.  Did NOT take more Paxlovid.  Cough.  Home test today, July 27, 2022, was very faintly positive.
Case number PHEH2014US006809 is an initial spontaneous report from the consumer received on 02 Apr 2014. This report refers to a 18-year-old male patient. He was vaccinated with FLUVIRIN (batch number: not reported) intramuscularly on an unknown date in Oct 2013. On 30 Mar 2014, he experienced flu symptoms. On 01 Apr 2014, lab test showed that swab was positive for influenza A. It was reported that there was a failure of flu vaccine. He was treated with TAMIFLU with improvement in 24 hours. The seriousness and causality of the events were not reported.
SORE THROAT; CONGESTION; COUGH; FEVER; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (SORE THROAT), NASAL CONGESTION (CONGESTION), COUGH (COUGH) and PYREXIA (FEVER) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (SORE THROAT), NASAL CONGESTION (CONGESTION), COUGH (COUGH) and PYREXIA (FEVER). At the time of the report, OROPHARYNGEAL PAIN (SORE THROAT), NASAL CONGESTION (CONGESTION), COUGH (COUGH) and PYREXIA (FEVER) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
This spontaneous report was received from a healthcare worker and refers to an unspecified number of patients of unknown demographics. The patients medical history, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with doses of GARDASIL lot # K008931, expiration date: 04-MAR-2017 (dose and route were not provided), which were exposed to temperatures outside of the recommended range. No adverse experience was reported. This is one of several reports received from the same reporter. Additional information has been requested.
headache on left front side of head, left side of jaw pain, muscle stiffness,  Diarrhea.
Swelling of arm from shoulder to elbow, skin hot to touch, soreness; Bad taste in mouth beginning approximately 5 minutes after shot administered and continued for two days; Vision changes: blurry vision and difficulty focusing; Fatigue and lack of appetite; Sharp pain in left arm pit;
The texter confirmed that they received moderna COVID-19 vaccine and had side effects.; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 28-May-2021 and was forwarded to Moderna on 28-May-2021. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (The texter confirmed that they received moderna COVID-19 vaccine and had side effects.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (The texter confirmed that they received moderna COVID-19 vaccine and had side effects.). At the time of the report, VACCINATION COMPLICATION (The texter confirmed that they received moderna COVID-19 vaccine and had side effects.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
No adverse etfects reported; patient received improperly stored dose of MMR II; This spontaneous report was received from a nurse and refers to a 4-year-old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 19-AUG-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) lot # R024905, expiration date 30-AUG-2020, albumin status rHA (dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the highest temperature excursion of above 47 degrees Fahrenheit (54 degrees Fahrenheit) for 17 hours and 15 minutes on 12-JUL-2019. Data logger was involved. There were no previous excursions reported.  This is one of several reports received from the same reporter.
felt high immediately after receiving each of the doses; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 01Mar2021 08:45 (Lot number: EN6202) at the age of 33 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Redundant Colon" (unspecified if ongoing); "Known Allergies- Penicillin" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Erythromycin, reaction(s): "allergy". The following information was reported: EUPHORIC MOOD (non-serious), outcome "recovering", described as "felt high immediately after receiving each of the doses". Therapeutic measures were not taken as a result of euphoric mood. Additional information: The patient had no other vaccine in four weeks and no other medications in two weeks. The patient had no COVID prior vaccination and was not COVID tested post vaccination.  No follow-up attempts are possible. No further information is expected.
bilateral cheek and forehead, and anterior neck redness, itching, burning, and tenderness with urticaria rash. no SOB or airway/lip/tongue/eyelid swelling